2seventy bio to Participate in the 2025 TD Cowen Healthcare Conference
2seventy bio (Nasdaq: TSVT) announced that its management team will participate in a fireside chat at the TD Cowen 45th Annual Healthcare Conference on March 5, 2025 at 11:10 a.m. ET in Boston, Mass. The event will be webcast live via the Investors and Media section of 2seventy bio’s website, with replays available for 30 days post-event.
2seventy bio is dedicated to accelerating the translation of human thought into action to combat cancer, aiming to provide more time to patients. The company has a profound understanding of the immune system's response to tumor cells and is focused on delivering the first FDA-approved CAR T cell therapy for multiple myeloma to as many patients as possible.
For more information, visit their website or follow them on social media platforms such as X (Twitter) and LinkedIn.
2seventy bio (Nasdaq: TSVT) ha annunciato che il suo team di gestione parteciperà a una chiacchierata informale al TD Cowen 45th Annual Healthcare Conference il 5 marzo 2025 alle 11:10 a.m. ET a Boston, Massachusetts. L'evento sarà trasmesso in diretta streaming nella sezione Investitori e Media del sito web di 2seventy bio, con repliche disponibili per 30 giorni dopo l'evento.
2seventy bio è dedicata ad accelerare la traduzione del pensiero umano in azione per combattere il cancro, con l'obiettivo di fornire più tempo ai pazienti. L'azienda ha una profonda comprensione della risposta del sistema immunitario alle cellule tumorali e si concentra sulla fornitura della prima terapia con cellule CAR T approvata dalla FDA per il mieloma multiplo a quante più pazienti possibile.
Per ulteriori informazioni, visita il loro sito web o seguili sulle piattaforme di social media come X (Twitter) e LinkedIn.
2seventy bio (Nasdaq: TSVT) anunció que su equipo de gestión participará en una charla informal en la TD Cowen 45th Annual Healthcare Conference el 5 de marzo de 2025 a las 11:10 a.m. ET en Boston, Massachusetts. El evento será transmitido en vivo a través de la sección de Inversores y Medios del sitio web de 2seventy bio, con repeticiones disponibles durante 30 días después del evento.
2seventy bio está dedicada a acelerar la traducción del pensamiento humano en acción para combatir el cáncer, con el objetivo de proporcionar más tiempo a los pacientes. La empresa tiene un profundo entendimiento de la respuesta del sistema inmunológico a las células tumorales y se centra en ofrecer la primera terapia con células CAR T aprobada por la FDA para el mieloma múltiple a la mayor cantidad posible de pacientes.
Para más información, visita su sitio web o síguelos en plataformas de redes sociales como X (Twitter) y LinkedIn.
2seventy bio (Nasdaq: TSVT)는 경영진이 TD Cowen 제45회 연례 헬스케어 컨퍼런스에서 2025년 3월 5일 오전 11시 10분 ET에 보스턴, 매사추세츠에서 화상 대화에 참여할 것이라고 발표했습니다. 이 행사는 2seventy bio 웹사이트의 투자자 및 미디어 섹션을 통해 실시간으로 방송되며, 행사 후 30일 동안 다시 볼 수 있습니다.
2seventy bio는 암과 싸우기 위해 인간의 생각을 행동으로 전환하는 것을 가속화하는 데 전념하고 있으며, 환자에게 더 많은 시간을 제공하는 것을 목표로 하고 있습니다. 이 회사는 종양 세포에 대한 면역 체계의 반응을 깊이 이해하고 있으며, 가능한 한 많은 환자에게 FDA 승인 CAR T 세포 치료법을 제공하는 데 집중하고 있습니다.
자세한 내용은 웹사이트를 방문하거나 X (Twitter) 및 LinkedIn과 같은 소셜 미디어 플랫폼에서 팔로우하세요.
2seventy bio (Nasdaq: TSVT) a annoncé que son équipe de direction participera à une discussion informelle lors de la TD Cowen 45th Annual Healthcare Conference le 5 mars 2025 à 11h10 ET à Boston, Massachusetts. L'événement sera diffusé en direct via la section Investisseurs et Médias du site web de 2seventy bio, avec des rediffusions disponibles pendant 30 jours après l'événement.
2seventy bio est dédiée à l'accélération de la traduction de la pensée humaine en action pour lutter contre le cancer, visant à offrir plus de temps aux patients. L'entreprise a une compréhension approfondie de la réponse du système immunitaire aux cellules tumorales et se concentre sur la fourniture de la première thérapie cellulaire CAR T approuvée par la FDA pour le myélome multiple à autant de patients que possible.
Pour plus d'informations, visitez leur site web ou suivez-les sur des plateformes de médias sociaux comme X (Twitter) et LinkedIn.
2seventy bio (Nasdaq: TSVT) gab bekannt, dass das Management-Team an einem informellen Gespräch auf der TD Cowen 45th Annual Healthcare Conference am 5. März 2025 um 11:10 Uhr ET in Boston, Massachusetts, teilnehmen wird. Die Veranstaltung wird live über den Bereich Investoren und Medien auf der Website von 2seventy bio übertragen, mit Wiederholungen, die 30 Tage nach der Veranstaltung verfügbar sind.
2seventy bio hat sich der Beschleunigung der Übersetzung menschlichen Denkens in Handlungen zur Bekämpfung von Krebs verschrieben, mit dem Ziel, den Patienten mehr Zeit zu geben. Das Unternehmen hat ein tiefes Verständnis für die Reaktion des Immunsystems auf Tumorzellen und konzentriert sich darauf, die erste von der FDA genehmigte CAR-T-Zelltherapie für multiples Myelom so vielen Patienten wie möglich anzubieten.
Für weitere Informationen besuchen Sie bitte ihre Website oder folgen Sie ihnen auf sozialen Medien wie X (Twitter) und LinkedIn.
- None.
- None.
A live webcast of the fireside chat will be available via the Investors and Media section of 2seventy bio’s website at https://ir.2seventybio.com/. Replays will be archived on 2seventy bio’s site for 30 days following the event.
About 2seventy bio
Our name, 2seventy bio, reflects why we do what we do - TIME. Cancer rips time away, and our goal is to work at the maximum speed of translating human thought into action – 270 miles per hour – to give the people we serve more time. With a deep understanding of the human body’s immune response to tumor cells and how to translate cell therapies into practice, we’re applying this knowledge to deliver the first FDA-approved CAR T cell therapy for multiple myeloma to as many patients as possible. Importantly, we remain focused on accomplishing our mission by staying genuine and authentic to our “why” and keeping our people and culture top of mind every day.
For more information, visit www.2seventybio.com.
Follow 2seventy bio on social media: X (Twitter) and LinkedIn.
2seventy bio is a trademark of 2seventy bio, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250225987379/en/
Investors and Media:
Vicki Eatwell, CFO
vicki.eatwell@2seventybio.com
Morgan (
Morgan.adams@2seventybio.com
Source: 2seventy bio, Inc.
FAQ
What is the significance of 2seventy bio's participation in the TD Cowen Healthcare Conference 2025?
When and where will 2seventy bio's fireside chat at the TD Cowen Healthcare Conference take place?
How can I access the live webcast of 2seventy bio's fireside chat at the 2025 TD Cowen Healthcare Conference?
How long will the replay of 2seventy bio's fireside chat be available?
What is 2seventy bio's mission?
What therapy is 2seventy bio focused on delivering?
